PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Digoxin - Arrhythmias
PAD Profile : Digoxin - Arrhythmias
Keywords :
atrial fibrillation, atrial flutter, cardiac glycosides
Brand Names Include :
Lanoxin
Traffic Light Status
Status 1 of 2.
Status :
Green
Important
Formulations :
- Elixir
- Tablets
Important Information :
ONE 62.5mcg tablet is equivalent to 50mcg (1ml) of elixir
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Amiodarone hydrochloride
- Flecainide acetate
- Propafenone hydrochloride
- Sotalol hydrochloride
- Atenolol
- Mexiletine hydrochloride
- Bisoprolol fumarate
- Disopyramide
- Lidocaine
- Metoprolol tartrate
- Procainamide hydrochloride
- Propranolol hydrochloride
- Verapamil hydrochloride
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 September 2020
Guidelines (Local)
01 September 2020
Committee Recommendations
Date
Committee Name
Narrative
06 December 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Updated Kent Surrey & Sussex Academic Health Science Network (KSS AHSN) Atrial Fibrillation pathways attached for information (See below)
01 July 2015
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.
Associated BNF Codes
02. Cardiovascular System
02.01.01. Cardiac glycosides